12:00 AM
 | 
Feb 14, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Hepsera adefovir dipivoxil infectious data

Researchers at Hannover Medical School and colleagues reported data from a German trial in 90 patients showing that the primary endpoint of normalization of ALT levels and clearance of HDV RNA at week 48 was reached by 2 patients receiving once-daily 10 mg Hepsera...

Read the full 198 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >